GlassScriptPhysician profile
Alan H Barrett
NPI 1922174119
$3,055.03
in general payments reported to CMS, 2019-2025
30 companies · $759 in 2025
The $759 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $460 · 2022: $461 · 2023: $559 · 2024: $817 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.42 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $973.16 | 2021-2025 | |
| Novo Nordisk INC | $607.08 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $229.07 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $144.38 | 2021-2025 | Otezla, Repatha, Otezla |
| Dexcom, INC. | $113.83 | 2023-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $105.07 | 2024-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $96.82 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.57 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.16 | 2022-2025 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $67.37 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.07 | 2025 | Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $52.03 | 2021-2023 | |
| Xeris Pharmaceuticals, INC. | $50.71 | 2022-2023 | Gvoke Hypopen |
| Pfizer INC. | $45.41 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $44.80 | 2021-2023 | Gardasil 9, Vaxneuvance |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $44.36 | 2025 | Clottriever Bold Catheter |
| Janssen Pharmaceuticals, INC | $38.82 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $31.63 | 2024 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $22.91 | 2022 | |
| Dynavax Technologies Corporation | $19.33 | 2024 | Heplisav-B |
| Exact Sciences Corporation | $17.97 | 2025 | Cologuard Collection Kit |
| Lundbeck LLC | $17.14 | 2023 | Rexulti |
| Hikma Pharmaceuticals USA | $16.76 | 2021 | |
| Eyevance Pharmaceuticals LLC | $16.76 | 2021 | |
| Upsher-Smith Laboratories LLC | $16.28 | 2021 | |
| Eisai INC. | $15.74 | 2021 | |
| Astellas Pharma US INC | $15.29 | 2021 | |
| Renalytix Ai, INC. | $14.80 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Paratek Pharmaceuticals, INC. | $13.65 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.